Dr Diane H Lubkeman, MD in Laurel, DE - Ophthalmology

Dr Diane H Lubkeman, MD is a Ophthalmology physician based in Laurel, Delaware. Dr Diane H Lubkeman is licensed to practice in Delaware (license number CI-0003154) and her current practice location is 116 E Front St, Ste A, Laurel, Delaware. She can be reached at her office (for appointments etc.) via phone at (410) 546-2500.

NPI number for Dr Diane H Lubkeman is 1790785145 and her current mailing address is 31519 Winterplace Pkwy, Ste 1, Salisbury, Maryland. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1790785145.

Contact Information

	Dr Diane H Lubkeman, MD
	116 E Front St, Ste A, Laurel, DE 19956-1722
	(410) 546-2500
	Not Available

Physician's Profile

Full Name	Dr Diane H Lubkeman
Gender	Female
Speciality	Ophthalmology
Location	116 E Front St, Laurel, Delaware
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1790785145
Provider Enumeration Date: 07/28/2005
Last Update Date: 01/31/2008

Medical Identifiers

Medical identifiers for Dr Diane H Lubkeman such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1790785145	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207W00000X	Ophthalmology	CI-0003154 (Delaware)	Primary
207W00000X	Ophthalmology	D0063035 (Maryland)	Secondary
207W00000X	Ophthalmology	MD032840E (Pennsylvania)	Secondary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Diane H Lubkeman is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Diane H Lubkeman, MD 31519 Winterplace Pkwy, Ste 1, Salisbury, MD 21804 Ph: (410) 546-2500	Dr Diane H Lubkeman, MD 116 E Front St, Ste A, Laurel, DE 19956-1722 Ph: (410) 546-2500

News Archive

Affitech, Cancer Research Technology sign deal to advance therapeutic antibodies

Cancer Research Technology, the commercial arm of Cancer Research UK, has signed a license agreement to grant antibody medicines company, Affitech A/S, exclusive rights to a CRT patent application and relevant know how to develop and use therapeutic antibodies that recognise and block the function of CCR4, a protein found on certain tumours - including early and late stage cervical cancer and oesophageal cancer.

Mindfulness meditation can reduce pain, anxiety in healthy individuals

When Rebecca Erwin was a varsity rower at the University of North Carolina, the coach had the team's members take a yoga and meditation class.

Today's selection of opinions and editorials

When Speaker Nancy Pelosi unveiled the revised House Democratic health care bill last week, the Obama White House hailed it as a "critical milestone" in the process. No doubt senior administration officials were relieved to see signs of "momentum" toward passage of something. But if the president really meant what he has said about health care policy throughout this year, his administration would be working to defeat the Pelosi bill, not supporting it (James Capretta).

Humanoid robot iCub enters rehabilitation facility to treat children with autism

For the first time in the world, the humanoid robot iCub, developed and built by researchers at IIT-Istituto Italiano di Tecnologia (Italian Institute of Technology), enters a rehabilitation facility to take part in an experimental therapy to treat cognitive impairments in children with autism spectrum condition.

Gut bacteria may influence the response to certain cancer therapies finds study

A latest study has found that patients with advanced melanoma or skin cancer who had a specific bacteria in their gut had a more favorable response to certain types of cancer treatment or immunotherapy. The study from the University of Texas was published in the latest issue of the journal Science.

Dr Diane H Lubkeman, MD - Ophthalmology in Laurel, DE